Tenascin-Y in the Developing and Adult Avian Nervous SystemTucker R.P.a · Hagios C.b · Chiquet-Ehrismann R.b
aDepartment of Cell Biology and Human Anatomy, School of Medicine, University of California at Davis, Calif., USA; bFriedrich Miescher Institute, Basel, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The glycoproteins tenascin-C and tenascin-R are abundant in the developing and adult nervous system, respectively. We have used a polyclonal antiserum to determine if tenascin-Y, a novel member of the tenascin family previously identified in the extracellular matrix of muscle, is also expressed in the avian nervous system. Beginning at embryonic day 3 tenascin-Y immunoreactivity is associated with bottle-shaped ependymal cells in the roof plate and floor plate of the spinal cord and brain. These cells resemble the secretory cells that synthesize the ventricular extracellular matrix, including Reissner’s fiber. Tenascin-Y immunoreactivity is also seen in pia mater and blood vessels in the developing and adult central nervous system. Anti-tenascin-Y stains the connective tissue sheath of peripheral nerves and the dorsal roots beginning around embryonic day 20. In vitro, sensory neurites fail to form lamellipodia when cultured in the presence of recombinant tenascin-Y, suggesting that tenascin-Y may play a role in inhibiting sensory neurite regeneration into the spinal cord. There is little overlap in the expression patterns of tenascin-Y and tenascin-C during development and between tenascin-Y and tenascin-R in the adult central nervous system, which is further evidence of distinctive mechanisms of gene regulation by the different members of the tenascin family.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.